Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide.
DRJ Singer(The University of Sydney), G. A. MacGregor, Michelle A. Miller(University of Warwick), A. Louise Sugden(Charing Cross Hospital), Nirmala D. Markandu(University of London)
Cited by 49
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340
DOUBLE-BLIND STUDY OF THREE SODIUM INTAKES AND LONG-TERM EFFECTS OF SODIUM RESTRICTION IN ESSENTIAL HYPERTENSION
|The Lancet|1989|272
Structural Skin Capillary Rarefaction in Essential Hypertension
|Hypertension|1999|259